Companies
San Raffaele Telethon Institute
a leading European gene-therapy research institute exploring epigenetic editing to improve CAR-T cell function (reducing T-cell exhaustion), and in 2026 announced a manufacturing-scale-up collaboration with Cytiva to address gene-therapy production bottlenecks.
- Country
- Italy
research
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Joint venture between Fondazione Telethon and Ospedale San Raffaele | research.hsr.it · sofinnovapartners.com · fondazionetelethon.it |
| Research focus | Gene and cell therapy, including gene and epigenetic editing, CAR-T cell engineering, and cancer immunotherapy | research.hsr.it · fondazionetelethon.it |
| Facility | Process Development Laboratory, GLP Test Facility, Vector Integration Core, Immune Core, Clinical Research Unit (including Clinical Hematology Research Unit and Pediatric Clinical Research Unit), SR-Tiget Clinical Lab | fondazionetelethon.it |
| Grant | ERC Consolidator Grants 2024, Armenise-Harvard Foundation grant, From Bed to Bench grant, Horizon Europe-European Innovation Council grant (X-PAND) | research.hsr.it · fondazionetelethon.it |
| Principal staff | Luigi Naldini (Director), Alessandro Aiuti (Deputy Director and Head of Research Unit) | fondazionetelethon.it |
| Headcount | Approximately 300 employees total (176 recorded in one source) | fondazionetelethon.it |
Independent sources: fondazionetelethon.it · research.hsr.it · sofinnovapartners.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Epigenome editing | genome-engineering | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.